Electrical neurostimulation for glaucoma with Sunita Radhakrishnan, MD
February 8th 2025Sunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.
Glaucoma devices and pharmaceuticals with John Berdahl, MD
February 7th 2025John Berdahl, MD, discusses a non-surgical, non-drug treatment for glaucoma approved by the FDA in 2024. The pump uses negative pressure to lower eye pressure by an average of 39% in clinical trials, with a good safety profile.
Study finds faricimab effective for nAMD patients unresponsive to other anti-VEGF treatments
February 6th 2025This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after 6 months of treatment in a retrospective chart review that included 102 patients with nAMD who had had suboptimal responses to other anti-VEGF therapies.
Leading ophthalmology forward: two milestones, one mission
January 31st 2025As Ophthalmology Times celebrates 50 years of publication and the Wilmer Eye Institute marks 100 years of academic leadership, Peter J. McDonnell, MD, reflects on their shared commitment to helping ophthalmologists improve patient outcomes.